Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Shares Issued (2016 - 2025)

Amicus Therapeutics' Shares Issued history spans 16 years, with the latest figure at $18.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 197.72% year-over-year to $18.7 million, compared with a TTM value of $19.2 million through Dec 2025, changed N/A, and an annual FY2025 reading of $19.2 million, changed N/A over the prior year.
  • Shares Issued for Q4 2025 was $18.7 million at Amicus Therapeutics, up from $339000.0 in the prior quarter.
  • The five-year high for Shares Issued was $18.7 million in Q4 2025, with the low at -$19.2 million in Q4 2024.
  • Average Shares Issued over 5 years is $1.8 million, with a median of $1.1 million recorded in 2022.
  • Year-over-year, Shares Issued soared 3230.0% in 2022 and then plummeted 893.41% in 2024.
  • Tracing FOLD's Shares Issued over 5 years: stood at $1.8 million in 2021, then tumbled by 39.28% to $1.1 million in 2022, then soared by 115.73% to $2.4 million in 2023, then plummeted by 893.41% to -$19.2 million in 2024, then skyrocketed by 197.72% to $18.7 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Shares Issued are $18.7 million (Q4 2025), $339000.0 (Q3 2025), and $40000.0 (Q2 2025).